Cloverfields Capital Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
20,495
+1,200
| +6% | +$145K | 0.74% | 56 |
|
|
2025
Q1 | $2.15M | Sell |
19,295
-83
| -0.4% | -$9.25K | 0.71% | 55 |
|
|
2024
Q4 | $1.89M | Buy |
19,378
+1,200
| +7% | +$117K | 0.61% | 57 |
|
|
2024
Q3 | $2.09M | Buy |
+18,178
| New | +$2.09M | 0.68% | 56 |
|
|
2023
Q2 | – | Sell |
-13,629
| Closed | -$1.25M | – | 83 |
|
|
2023
Q1 | $1.25M | Buy |
13,629
+7,443
| +120% | +$685K | 0.37% | 49 |
|
|
2022
Q4 | $561K | Buy |
+6,186
| New | +$561K | 0.18% | 51 |
|